TransOral Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Many biotechs specializing in drug delivery techniques--including TransOral Pharmaceuticals Inc.--are working to speed the onset of drug action for existing therapeutics. For example, in drugs for pain, the faster a drug's onset of action, the faster the pain relief. TransOral, founded in January 2002, is trying a transmucosal approach, but is directing its efforts solely at the tissues of the mouth by developing lozenges, gum, and similar dosage forms.